Read More

NanoString Comments On Unified Patent Court Order; Says “We Are Disappointed With Today’s Decision By The UPC And Will Immediately Appeal The Preliminary Injunction In The UPC Court Of Appeal In Luxembourg”

NanoString Will Immediately Appeal Preliminary Injunction Temporarily Blocking NanoString's Ability to Market and Sell CosMx Spatial Molecular Imager Products for RNA Detection within UPC Member Countries in

NSTG

Read More

Hope For Postpartum Depression: This Company To Launch Clinical Trial On Next-Gen Psychedelic

Clinical-stage biopharma company Reunion Neuroscience has received the FDA’s clearance on its Investigational New Drug (IND) application to begin a Phase 2 study of RE104, a novel serotonergic psychedelic compound aimed at treating postpartum depression (PPD.) 

MSSTF